ArticleIEEE access : practical innovations, open solutions2020
A Novel Parametric Model for the Prediction and Analysis of the COVID-19 Casualties.
Article in IEEE access : practical innovations, open solutions, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Biserial targeted feature projection based radial kernel regressive deep belief neural learning for covid-19 prediction.Soft computing · 2023Article
- Deming least square regressed feature selection and Gaussian neuro-fuzzy multi-layered data classifier for early COVID prediction.Expert systems · 2022Article
- Linear and non-linear dynamics of the epidemics: System identification based parametric prediction models for the pandemic outbreaks.ISA transactions · 2022Article
- Priority and age specific vaccination algorithm for the pandemic diseases: a comprehensive parametric prediction model.BMC medical informatics and decision making · 2022Article
- Unknown uncertainties in the COVID-19 pandemic: Multi-dimensional identification and mathematical modelling for the analysis and estimation of the casualties.Digital signal processing · 2021Article
- Development of a Multi-Dimensional Parametric Model With Non-Pharmacological Policies for Predicting the COVID-19 Pandemic Casualties.IEEE access : practical innovations, open solutions · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease (COVID-19) outbreak has affected billions of people, where millions of them have been infected and thousands of them have lost their lives. In addition, to constraint the spread of the virus, economies have been shut down, curfews and restrictions have interrupted the social lives. Currently, the key question in minds is the future impacts of the virus on the people. It is a fact that the parametric modelling and analyses of the pandemic viruses are able to provide crucial information about the character and also future behaviour of the viruses. This paper initially reviews and analyses the Susceptible-Infected-Recovered (SIR) model, which is extensively considered for the estimation of the COVID-19 casualties. Then, this paper introduces a novel comprehensive higher-order, multi-dimensional, strongly coupled, and parametric Suspicious-Infected-Death (SpID) model. The mathematical analysis results performed by using the casualties in Turkey show that the COVID-19 dynamics are inside the slightly oscillatory, stable (bounded) region, although some of the dynamics are close to the instability region (unbounded). However, analysis with the data just after lifting the restrictions reveals that the dynamics of the COVID-19 are moderately unstable, which would blow up if no actions are taken. The developed model estimates that the number of the infected and death individuals will converge zero around 300 days whereas the number of the suspicious individuals will require about a thousand days to be minimized under the current conditions. Even though the developed model is used to estimate the casualties in Turkey, it can be easily trained with the data from the other countries and used for the estimation of the corresponding COVID-19 casualties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.